Prostate Cancer: Translational And Emerging Therapies (Record no. 33104)

MARC details
000 -LEADER
fixed length control field 00946nam a2200205z 4500
001 - CONTROL NUMBER
control field 23632553
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190722 xxu eng|d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780367390181
Terms of availability 116.00
040 ## - CATALOGING SOURCE
Original cataloging agency NJB
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dawson, Nancy A,
Relator term Editor.
9 (RLIN) 98580
245 10 - TITLE STATEMENT
Title Prostate Cancer: Translational And Emerging Therapies
Medium [paperback]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Boca Raton, USA
Name of publisher, distributor, etc. CRC Press
Date of publication, distribution, etc. 2019.
300 ## - PHYSICAL DESCRIPTION
Extent 330 p.
Dimensions 23 cm.
520 ## - SUMMARY, ETC.
Summary, etc. Scientists have reached a critical point in the development of new therapies for prostate cancer. The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data has expanded the physician's understanding of disease progression and widened his armamentarium for prostate cancer preventio
521 ## - TARGET AUDIENCE NOTE
Target audience note Tertiary/Undergraduate.
521 ## - TARGET AUDIENCE NOTE
Target audience note Postgraduate.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kelly, W. Kevin,
Relator term Editor.
9 (RLIN) 98581
960 ## - PHYSICAL LOCATION (RLIN)
-- o
-- 1
-- 78.88
-- SLWAA
961 ## -
-- SLWAnort
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Full call number Barcode Date last seen Cost, replacement price Price effective from Koha item type
          Northam Northam Northam Adult Nonfiction 23/03/2020 2 116.00 616 .99463 PEO 31111077181764 14/02/2022 0.00 23/03/2020 wnor- Book